Bolna AS primarily invests in small-cap life science and technology companies in the Nordic region using a bottom-up approach focusing on company fundamentals and proprietary analysis, including product data evaluation. The company’s long-only portfolio aims to achieve long-term outperformance through superior stock selection rather than sector rotation. Bolna AS creates a diversified portfolio consisting mainly of small-cap life science and technology shares, which mitigates the impact of individual stocks. This investment style offers high growth potential and benefits from different demographic trends. Additionally, small-cap companies are attractive targets for mergers and acquisitions, which can increase investment value.
The Nordic region is known for its political stability, strong business culture, and sound corporate governance. The region has a reputation for being business-friendly and having high transparency and accountability. These factors make the Nordic countries an attractive location for investment, particularly in the life science and technology sectors.